Rheologics Appoints Dan Cho to Management Team.

EXTON, Pa. -- Rheologics Inc., a subsidiary of Rheologics Technologies, Inc. (RTGI.PK) announced today the appointment of Daniel Cho to its Managing Director team. Mr. Cho, a Harvard College graduate, will officially serve as Assistant Managing Director and be responsible for overseeing Rheologics'

Dr. Ken Kensey, founder of Rheologics and Chief Scientific Officer commented, "We are very pleased to have Dan join our staff. He has been involved with the Company as a consultant for over five years during our R&D phase and has amassed a vast knowledge of blood flow dynamics. He knows the Rheolog(TM) inside and out. His guidance and insight will help us take the Company to the next level."

Rheologics, Inc., is the leader in the study of blood viscosity and its relationship to cardiovascular disease (CVD). Dr. Ken Kensey, an internationally renowned cardiologist, inventor, author, and co-founder of Kensey Nash Corp. (NASDAQ:KNSY), formed Rheologics after years of extensive research specifically to create a device, trademarked the Rheolog(TM), that could more accurately measure whole blood viscosity. The Company has been testing the Rheolog(TM) with prominent research clinics for over three years and is now positioned to begin commercialization. On behalf of Rheologics, Dr. Kensey stated, "We believe that the Rheolog(TM) is comparable to the invention of the electron microscope in 1931 and the blood pressure monitor before that in 1905. With our device we can now begin to closely examine the dynamics of blood viscosity and its effect on a number of chronic diseases, most notably cardiovascular disease. In clinical research that has been conducted using the Rheolog(TM), we have been able to see that elevated whole blood viscosity plays a significant role in a number of heart and health-related issues, including Alzheimer's, diabetes, atherosclerosis and other inflammatory disorders. We look forward to the Rheolog(TM) becoming an invaluable tool in the physician's office, at the bedside, and in the laboratory."

Mr. Cho brings to Rheologics his exceptional expertise in engineering, licensing, and business development. For the past six years, he has served as President and CEO of Vortex Aircon, Inc., a privately-held corporation that provides energy-efficient technologies for the appliance industry. "I believe that Rheologics is in a unique position to now bring its technology to fruition," Cho commented. "I am very excited to be a part of the Company's growth."

Safe Harbor for Forward-Looking Statements: Except for historical information contained herein, the statements in this Press Release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause the Company's actual results in the future periods to differ materially from forecasted results. These risks and uncertainties include, among other things, product price volatility, product demand, market competition, risk inherent in the Company's operations, imprecision in estimating product reserves and the Company's ability to replace and expand its real estate and software interests. Rheologics Technologies, Inc. assumes no obligation to update the information contained in this press release, whether as a result of new information, future events or otherwise.